We’re here for the cure. Cure Parkinson’s is working with urgency to find new treatments to slow, stop and reverse Parkinson’s. Our funding and innovation has redefined the field of Parkinson’s research, enabling the world’s leading researchers to prioritise the next generation of drugs for clinical trial. Together we will conquer Parkinson’s.

All videos on this channel are protected by copyright. Please don't reupload or redistribute any Cure Parkinson's content without permission. If you'd like to use something, feel free to reach out to us for approval. Reuploads without consent may result in copyright claims or other actions. Thanks you for respecting our work.

A Decade of Clinical Trials in Parkinson’s: Focus on LRRK2 and GBA1 (Rallying 2025)
31:14
A Decade of Clinical Trials in Parkinson’s: Focus on LRRK2 and GBA1 (Rallying 2025)
EJS ACT-PD: the world's largest clinical trial for Parkinson's
3:21
EJS ACT-PD: the world's largest clinical trial for Parkinson's
The Parkinson’s Plan Book – Prevention, The Parkinson’s 25, and Pursuit of a Cure (Rallying 2025)
26:13
The Parkinson’s Plan Book – Prevention, The Parkinson’s 25, and Pursuit of a Cure (Rallying 2025)
2025 Tom Isaacs Award honours Parkinson’s expert Dr Matthew Farrer
9:05
2025 Tom Isaacs Award honours Parkinson’s expert Dr Matthew Farrer
What are combination therapies? (Rallying 2025)
19:15
What are combination therapies? (Rallying 2025)
Impact of the International Linked Clinical Trials (iLCT) Programme (Rallying 2025)
28:20
Impact of the International Linked Clinical Trials (iLCT) Programme (Rallying 2025)
An Interview with Dr Tim Greenamyre – Hosted by Prof David K. Simon (Rallying 2025)
45:12
An Interview with Dr Tim Greenamyre – Hosted by Prof David K. Simon (Rallying 2025)
What is Mitophagy? Mitochondrial Health and Targeting USP30 (Rallying 2025)
34:17
What is Mitophagy? Mitochondrial Health and Targeting USP30 (Rallying 2025)
Introduction to Cell Biology: Mitochondria and Energy Production (Rallying 2025)
14:02
Introduction to Cell Biology: Mitochondria and Energy Production (Rallying 2025)
Genetic Testing for Parkinson’s: Considerations and Participation (Rallying 2025)
32:07
Genetic Testing for Parkinson’s: Considerations and Participation (Rallying 2025)
Genetic Screening for LRRK2 – Importance of Patient Stratification (Rallying 2025)
32:38
Genetic Screening for LRRK2 – Importance of Patient Stratification (Rallying 2025)
LRRK2 Inhibition: From Biology to the Clinic (Rallying 2025)
19:56
LRRK2 Inhibition: From Biology to the Clinic (Rallying 2025)
The Origin Story of LRRK2 Parkinson’s: From the What, Where and Why to the How (Rallying 2025)
36:34
The Origin Story of LRRK2 Parkinson’s: From the What, Where and Why to the How (Rallying 2025)
Introduction to Cell Biology: Genetics and Waste Disposal System (Rallying 2025)
19:11
Introduction to Cell Biology: Genetics and Waste Disposal System (Rallying 2025)
Webinar: Deep Brain Stimulation (DBS) for Parkinson's - The next steps
59:33
Webinar: Deep Brain Stimulation (DBS) for Parkinson's - The next steps
Special Update Meeting: Overview of the field of cell replacement therapies – Dr Agnete Kirkeby
1:06:44
Special Update Meeting: Overview of the field of cell replacement therapies – Dr Agnete Kirkeby
Special Update Meeting: Panel discussion and Q&A - Considerations around cell and complex therapies
50:35
Special Update Meeting: Panel discussion and Q&A - Considerations around cell and complex therapies
Special Update Meeting: A conversation with Andy Cassy, participant in the STEM-PD trial
36:50
Special Update Meeting: A conversation with Andy Cassy, participant in the STEM-PD trial
A Question of Time: help find a cure for Parkinson's
1:52
A Question of Time: help find a cure for Parkinson's
ASPro-PD: Phase 3 Trial of Ambroxol - Dr Marco Toffoli, Mairead Cullen, Prof Anthony Schapira
36:44
ASPro-PD: Phase 3 Trial of Ambroxol - Dr Marco Toffoli, Mairead Cullen, Prof Anthony Schapira
2025 Spring Research Update Meeting - Panel discussion and Q&A
54:35
2025 Spring Research Update Meeting - Panel discussion and Q&A
An Introduction to the UK Parkinson's Disease Clinical Study Group - Emma Fargher
5:03
An Introduction to the UK Parkinson's Disease Clinical Study Group - Emma Fargher
Testing iLCT-evaluated compounds in patient-derived neurons - Dr Francesco Capriglia
5:08
Testing iLCT-evaluated compounds in patient-derived neurons - Dr Francesco Capriglia
PD Frontline: Genetic Testing for Parkinson’s - Amelia Anderson, Georgia Pittwood
23:11
PD Frontline: Genetic Testing for Parkinson’s - Amelia Anderson, Georgia Pittwood
Cure Parkinson's Spring Research Update - Dr Simon Stott
14:20
Cure Parkinson's Spring Research Update - Dr Simon Stott
Webinar: Addressing the sex and gender gaps in Parkinson's research
59:41
Webinar: Addressing the sex and gender gaps in Parkinson's research
Exenatide PD3: Initial Findings and Learnings - Professor Tom Foltynie
1:34:57
Exenatide PD3: Initial Findings and Learnings - Professor Tom Foltynie
Webinar: Advancing Parkinson's trial designs
1:00:24
Webinar: Advancing Parkinson's trial designs
Georgia Mills: EJS ACT-PD: A MAMS UK Platform Trial to Accelerate Research for Parkinson’s
6:40
Georgia Mills: EJS ACT-PD: A MAMS UK Platform Trial to Accelerate Research for Parkinson’s
Dr Chengsheng Ju: Trial emulation to assess effect of LTRAs on Parkinson's & neuropsychiatric events
4:05
Dr Chengsheng Ju: Trial emulation to assess effect of LTRAs on Parkinson's & neuropsychiatric events